Literature DB >> 8612292

HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors.

A H Patki1, M M Lederman.   

Abstract

To explore further the effects of the HIV-1 transactivator protein Tat on human lymphoid cell function we examined the effects of Tat on lymphocyte proliferation and programmed cell death (apoptosis). We found that the HIV-1 Tat protein induced apoptosis and inhibited lymphocyte proliferative responses in lymphocytes obtained from healthy HIV-1 seronegative donors. Surprisingly, the Tat inhibitor Ro 24-7429 also induced apoptosis and inhibited antigen-induced lymphocyte proliferation. In checkerboard experiments, each agent could antagonize the effects of the other in both assays. These data suggest that Tat and its inhibitor may interact with a host element critically important in the processes of lymphocyte proliferation and programmed cell death. The HIV-1 Tat protein may affect both lymphocyte survival and function in HIV-1 infection, thereby contributing to the immune deficiency of HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612292     DOI: 10.1006/cimm.1996.0088

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells.

Authors:  C Cicala; J Arthos; A Rubbert; S Selig; K Wildt; O J Cohen; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.

Authors:  S A Stewart; B Poon; J B Jowett; I S Chen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.

Authors:  Vivek Narayan; Kodihalli C Ravindra; Chris Chiaro; Daniele Cary; Bharat B Aggarwal; Andrew J Henderson; K Sandeep Prabhu
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

4.  CD4+-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects.

Authors:  A H Patki; D L Georges; M M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

5.  Decreased ability of HIV-1 tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells.

Authors:  M X Wu; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env.

Authors:  Michael J Lenardo; Sara B Angleman; Viengngeun Bounkeua; Joseph Dimas; Melody G Duvall; Moses B Graubard; Felicita Hornung; Marianne C Selkirk; Christina K Speirs; Carol Trageser; Jan O Orenstein; Diane L Bolton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.

Authors:  Satoshi Komoto; Shoutaro Tsuji; Madiha S Ibrahim; Yong-Gang Li; Jiranan Warachit; Koki Taniguchi; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.

Authors:  Parisa Kalantari; Vivek Narayan; Andrew J Henderson; K Sandeep Prabhu
Journal:  FASEB J       Date:  2009-03-19       Impact factor: 5.191

9.  Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.

Authors:  Naveed Ahmed Khan; Francescopaolo Di Cello; Avi Nath; Kwang Sik Kim
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

10.  Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages.

Authors:  Parisa Kalantari; Vivek Narayan; Sathish K Natarajan; Kambadur Muralidhar; Ujjawal H Gandhi; Hema Vunta; Andrew J Henderson; K Sandeep Prabhu
Journal:  J Biol Chem       Date:  2008-10-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.